| 1 |
35157045 | Sunitinib inhibits STAT3 phosphorylation in cardiac muscle and prevents cardiomyopathy in the mdx mouse model of Duchenne muscular dystrophy. | 2022 Feb 14 |
1 |
| 2 |
35562668 | RNF7 inhibits apoptosis and sunitinib sensitivity and promotes glycolysis in renal cell carcinoma via the SOCS1/JAK/STAT3 feedback loop. | 2022 May 13 |
1 |
| 3 |
34367125 | Receptor Tyrosine Kinase Inhibitor Sunitinib as Novel Immunotherapy to Inhibit Myeloid-Derived Suppressor Cells for Treatment of Endometriosis. | 2021 |
1 |
| 4 |
29633072 | Association of Expression Levels or Activation Status of STAT3 with Treatment Outcomes of Sunitinib in Patients with Renal Cell Carcinoma. | 2018 Jun |
4 |
| 5 |
28123542 | Influence of VEGFR single nucleotide polymorphisms on the efficacy of sunitinib therapy against renal cell carcinoma. | 2017 Jan |
2 |
| 6 |
28381801 | Association of Single Nucleotide Polymorphisms in STAT3, ABCB1, and ABCG2 with Stomatitis in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib: A Retrospective Analysis in Japanese Patients. | 2017 |
3 |
| 7 |
25922428 | Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy. | 2015 Sep 15 |
1 |
| 8 |
28031890 | Role of STAT3 pathway in genitourinary tumors. | 2015 Nov |
1 |
| 9 |
25013907 | Association of toxicity of sorafenib and sunitinib for human keratinocytes with inhibition of signal transduction and activator of transcription 3 (STAT3). | 2014 |
9 |
| 10 |
23471661 | Sunitinib reverse multidrug resistance in gastric cancer cells by modulating Stat3 and inhibiting P-gp function. | 2013 Nov |
3 |
| 11 |
23867518 | Modification of the tumor microenvironment as a novel target of renal cell carcinoma therapeutics. | 2013 Jul-Aug |
1 |
| 12 |
21792888 | Simultaneous targeting of Src kinase and receptor tyrosine kinase results in synergistic inhibition of renal cell carcinoma proliferation and migration. | 2012 Jun 1 |
1 |
| 13 |
21343371 | IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer. | 2011 Apr 15 |
1 |
| 14 |
20053726 | Sunitinib induces apoptosis and growth arrest of medulloblastoma tumor cells by inhibiting STAT3 and AKT signaling pathways. | 2010 Jan |
4 |
| 15 |
20629553 | Sunitinib inhibits MEK/ERK and SAPK/JNK pathways and increases sodium/iodide symporter expression in papillary thyroid cancer. | 2010 Sep |
1 |
| 16 |
21118964 | Targeting STAT3 in adoptively transferred T cells promotes their in vivo expansion and antitumor effects. | 2010 Dec 1 |
1 |
| 17 |
16849418 | An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/papillary thyroid cancer kinases. | 2006 Oct |
2 |